In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine

Barter, 2007, Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver, Curr. Drug Metab, 8, 33, 10.2174/138920007779315053 Billoir, 2007, Integrating the lethal and sublethal effects of toxic compounds into the population dynamics of Daphnia magna: a combination of the DEBtox and matrix population models, Ecol. Modell, 203, 204, 10.1016/j.ecolmodel.2006.11.021 Bronaugh, 1986, Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin, Br. J. Dermatol, 115, 1, 10.1111/j.1365-2133.1986.tb06214.x Carrier, 1988, Maturation of caffeine metabolic pathways in infancy, Clin. Pharmacol. Ther, 44, 145, 10.1038/clpt.1988.129 Chambin-Remoussenard, 1993, Surface recovery and stripping methods to quantify percutaneous absorption of caffeine in humans, J. Pharm. Sci, 82, 1099, 10.1002/jps.2600821107 Csajka, 2005, Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects, Br. J. Clin. Pharmacol, 59, 335, 10.1111/j.1365-2125.2005.02254.x Dias, 1999, Topical delivery of caffeine from some commercial formulations, Int. J. Pharm, 182, 41, 10.1016/S0378-5173(99)00067-8 Dimitrov, 2005, Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates, Int. J. Toxicol, 24, 189, 10.1080/10915810591000631 Doucet, 1998, O/W emulsion and W/O/W multiple emulsion: physical characterization and skin pharmacokinetic comparison in the delivery process of caffeine, Int. J. Cosmet. Sci, 20, 283, 10.1046/j.1467-2494.1998.181621.x Feldmann, 1970, Absorption of some organic compounds through the skin in man, J. Invest. Dermatol, 54, 399, 10.1111/1523-1747.ep12259184 Franz, 1978, The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man, Curr. Probl. Dermatol, 7, 58, 10.1159/000401276 Gajewska, 2014, Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients, Toxicol. Lett, 227, 10.1016/j.toxlet.2014.03.013 Gérard, 2009, Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle, Proc. Natl. Acad. Sci. U.S.A., 106, 21643, 10.1073/pnas.0903827106 Ginsberg, 2004, Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents, J. Toxicol. Environ. Health Part A, 67, 297, 10.1080/15287390490273550 Ha, 1996, Biotransformation of caffeine by cDNA-expressed human cytochromes P-450, Eur. J. Clin. Pharmacol, 49, 309, 10.1007/BF00226333 Herman, 2012, Caffeine's mechanisms of action and its cosmetic use, Skin Pharmacol. Physiol, 26, 8, 10.1159/000343174 Lehman, 2011, Percutaneous absorption in man: in vitro-in vivo correlation, Skin Pharmacol. Physiol, 24, 224, 10.1159/000324884 Lelo, 1986, Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man, Br. J. Clin. Pharmacol, 22, 177, 10.1111/j.1365-2125.1986.tb05246.x Liu, 2011, Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man, Br. J. Clin. Pharmacol, 72, 768, 10.1111/j.1365-2125.2011.04022.x Lopes, 2005, Ecotoxicology and population dynamics: using DEBtox models in a Leslie modeling approach, Ecol. Modell, 188, 30, 10.1016/j.ecolmodel.2005.05.004 Lotte, 1993, Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects, Arch. Dermatol. Res, 284, 456, 10.1007/BF00373356 Mennecozzi, 2011, Hepatotoxicity screening taking a mode-of-action approach using HepaRG cells and HCA, Altex Proc, 1/12 Moré, 1978, The Levenberg-Marquardt algorithm: implementation and theory, Lect. Notes Math, 630, 105, 10.1007/BFb0067700 Newton, 1981, Plasma and salivary pharmacokinetics of caffeine in man, Eur. J. Clin. Pharmacol, 21, 45, 10.1007/BF00609587 OECD SIDS, 2002. Caffeine: SIDS initial assessment report for SIAM 14. Otberg, 2008, The role of hair follicles in the percutaneous absorption of caffeine, Br. J. Clin. Pharmacol, 65, 488, 10.1111/j.1365-2125.2007.03065.x Regal, 2005, Oxidation of caffeine by CYP1A2: isotope effects and metabolic switching, Drug Metab. Dispos, 33, 1837 Roskos, 1989, The effect of aging on percutaneous absorption in man, J. Pharmacokinet. Biopharm, 17, 617, 10.1007/BF01062121 Venkatakrishnan, 2000, Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from CDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches, Drug Metab. Dispos, 28, 1493 Wilkinson, 2006, Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies, Int. Arch. Occup. Environ. Health, 79, 405, 10.1007/s00420-005-0056-5 Zaldívar, J.M., Mennecozzi, M., Marcelino Rodrigues, R., Bouhifd, M., 2010. A biology-based dynamic approach for the modelling of toxicity in cell-based assays. Part I: fate modelling. Zaldívar, J.M., Menecozzi, M., Macko, P., Rodriguez, R., Bouhifd, M., Baraibar Fentanes, J., 2011. A biology-based dynamic approach for the modelling of toxicity in cell assays. Part II: models for cell population growth and toxicity. Zandvliet, 2005, Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine, Basic Clin. Pharmacol. Toxicol, 96, 71, 10.1111/j.1742-7843.2005.pto960111.x